» Articles » PMID: 24938314

Insulin Detemir Treatment in Diabetic Cats in a Practice Setting

Overview
Date 2014 Jun 19
PMID 24938314
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin detemir is a long-acting insulin analogue and may represent a valuable treatment option for diabetic cats. So far, only one study addressing detemir treatment of diabetic cats has been published, and this was based on an intensive blood glucose monitoring protocol. The aim of the current, retrospective study was to evaluate the effect of detemir therapy in diabetic cats in a general clinical setting. Fourteen diabetic cats with a follow-up period of at least 3 months were included. Data were collected from medical records at the University Hospital for Companion Animals, University of Copenhagen, Denmark. Thirteen of 14 cats achieved moderate or excellent control of clinical symptoms within the initial 3 months of detemir therapy, including five cats previously treated unsuccessfully with other types of insulin. Clinical improvements were noted after 1 month of therapy and continued over time. Three cats achieved remission within the initial 3 months and none experienced a diabetic relapse during the study period. One cat achieved remission after 13 months of therapy. Improvements in clinical symptoms were markedly better than indicated by blood glucose and serum fructosamine concentrations. The safety of detemir was very high, with only two reported episodes of clinical hypoglycaemia, neither of which required veterinary attention. Based on these results detemir can be recommended for the treatment of diabetic cats, including cats previously treated unsuccessfully with other types of insulin.

Citing Articles

Loose-control of diabetes mellitus with protamine zinc insulin in cats: 185 cases (2005-2015).

Restine L, Norsworthy G, Kass P Can Vet J. 2019; 60(4):399-404.

PMID: 30992596 PMC: 6417615.


Update on insulin treatment for dogs and cats: insulin dosing pens and more.

Thompson A, Lathan P, Fleeman L Vet Med (Auckl). 2018; 6:129-142.

PMID: 30101100 PMC: 6067590. DOI: 10.2147/VMRR.S39984.


ABVP roundtable regarding management of diabetic cats.

Krecic M, Litster A J Feline Med Surg. 2016; 18(3):249-50.

PMID: 26936497 PMC: 11148905. DOI: 10.1177/1098612X16631236.


ISFM consensus guidelines on the practical management of diabetes mellitus in cats.

Sparkes A, Cannon M, Church D, Fleeman L, Harvey A, Hoenig M J Feline Med Surg. 2015; 17(3):235-50.

PMID: 25701862 PMC: 11148891. DOI: 10.1177/1098612X15571880.

References
1.
Martin G, Rand J . Pharmacology of a 40 IU/ml porcine lente insulin preparation in diabetic cats: findings during the first week and after 5 or 9 weeks of therapy. J Feline Med Surg. 2001; 3(1):23-30. PMC: 10822203. DOI: 10.1053/jfms.2001.0111. View

2.
Bertoy E, Nelson R, Feldman E . Effect of lente insulin for treatment of diabetes mellitus in 12 cats. J Am Vet Med Assoc. 1995; 206(11):1729-31. View

3.
Wess G, Reusch C . Assessment of five portable blood glucose meters for use in cats. Am J Vet Res. 2000; 61(12):1587-92. DOI: 10.2460/ajvr.2000.61.1587. View

4.
Goossens M, Nelson R, Feldman E, Griffey S . Response to insulin treatment and survival in 104 cats with diabetes mellitus (1985-1995). J Vet Intern Med. 1998; 12(1):1-6. DOI: 10.1111/j.1939-1676.1998.tb00489.x. View

5.
Nelson R, Griffey S, Feldman E, Ford S . Transient clinical diabetes mellitus in cats: 10 cases (1989-1991). J Vet Intern Med. 1999; 13(1):28-35. View